Russell L. Rothman, M.D., M.P.P.

Internal Medicine, Pediatrics, & Health Policy
Senior Vice President for Population Health Research
Chief, Internal Medicine & Pediatrics Section
Institute for Medicine and Public Health
Ingram Chair in Integrative and Population Health

Office Address
2525 West End Ave
Room / Suite
(615) 936-2149
(615) 936-1269

Dr. Rothman is Professor of Internal Medicine, Pediatrics and Health Policy, Ingram Professor of Integrative and Population Health, and the Senior Vice President for Population and Public Health at Vanderbilt University Medical Center. He also serves as the Director of the Institute for Medicine and Public Health and Chief of the Internal Medicine/Pediatrics Section. The Institute for Medicine and Public Health engages over 250 faculty involved in research and education related to global health, epidemiology, health services research, health policy, biomedical ethics, biostatistics, and other fields. Key areas of research include implementation science, population health, behavioral research, health disparities, quality improvement, learning health system approaches, and other areas aimed at improving health outcomes. Dr. Rothman's research focuses on improving care for adult and pediatric patients with diabetes, obesity and other chronic diseases. His research focuses on addressing health communication, health literacy/numeracy, and other social and behavioral factors to improve health. He has been the Principal Investigator on over $60 million in funded research and has authored over 150 manuscripts. He is currently the Principal Investigator of the STAR (Stakeholders, Technology and Research) Clinical Research Network, which engages Vanderbilt, Meharry, Duke, UNC, Wake Forest, Health Sciences of South Carolina, and Mayo in real world evidence and pragmatic research. Dr. Rothman served as Chair of the PCORI PCORnet Executive Steering Committee, which built a national network to support comparative effectiveness research and pragmatic clinical trials. Dr. Rothman serves as the Co-Chair of the Steering Committee of the ADAPTABLE study, a pragmatic clinical trial enrolling 15,000 patients to evaluate the optimal dose of aspirin in secondary prevention of heart disease. Dr. Rothman also serves as Co-Chair of the Steering Committee of the Healthcare workers Exposure Response and Outcomes (HERO)Study, which includes a national registry and clinical trials of healthcare workers and COVID19. Dr. Rothman is also the past president of the Academy of Communication in Healthcare (ACH).